Concurrent modulation of extracellular levels of noradrenaline and cAMP during stress and by anxiogenic- or anxiolytic-like neuropeptides in the prefrontal cortex of awake rats

Neurochemistry International

Volumn 62, Issue 3, 2013, Pages 314-323

  Yoshitake, Shimako ^a   Ijiri, Soichiro ^c   Kehr, Jan ^a,b   Yoshitake, Takashi ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Pronexus Analytical AB   (Sweden)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

cAMP; Fluorescence derivatization; Microdialysis; Neuropeptides; Noradrenaline; Rat

Indexed keywords

ANXIOLYTIC AGENT; CHLOROACETALDEHYDE; CHOLECYSTOKININ OCTAPEPTIDE; CYCLIC AMP; FORSKOLIN; GALANIN; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTENSIN; NOCICEPTIN; NORADRENALIN; SOMATOSTATIN; SUBSTANCE P; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DERIVATIZATION; DOSE RESPONSE; FLUORESCENCE; FORCED SWIMMING TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRESS; TRANQUILIZING ACTIVITY; WAKEFULNESS;

ANIMALS; BEHAVIOR, ANIMAL; CHOLECYSTOKININ; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; GALANIN; MALE; MICRODIALYSIS; NEUROKININ A; NEUROPEPTIDES; NOREPINEPHRINE; PEPTIDE FRAGMENTS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE; STRESS, PHYSIOLOGICAL; SUBSTANCE P;

RATTUS;

EID: 84873358266     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.12.011     Document Type: Article

References (84)

1. S.P. Alexander, A. Mathie, and J.A. Peters Guide to Receptors and Channels (GRAC), 5th edition Br. J. Pharmacol. 164 Suppl. 1 2011 S1 S324
2. R. Barber, and R.W. Butcher The turnover of cyclic AMP in cultured fibroblasts J. Cyclic Nucleotide Res. 6 1980 3 14 (Pubitemid 10149361)
3. C. Becker, M.H. Thièbot, Y. Touitou, M. Hamon, F. Cesselin, and J.J. Benoliel Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat J. Neurosci. 21 2001 262 269 (Pubitemid 32098749)
4. M.C. Beinfeld, D.K. Meyer, R.L. Eskay, R.T. Jensen, and M.J. Brownstein The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay Brain Res. 212 1981 51 57 (Pubitemid 11100783)
5. M. Birnbaumer Vasopressin receptors Trends Endocrinol. Metab. 11 2000 406 410
6. J. Bradwejn Neurobiological investigations into the role of cholecystokinin in panic disorder J. Psychiatry Neurosci. 18 1993 178 188 (Pubitemid 23255883)
7. T.A. Branchek, K.E. Smith, C. Gerald, and M.W. Walker Galanin receptor subtypes Trends Pharmacol. Sci. 21 2000 109 117 (Pubitemid 30114326)
8. K. Brodin, A. Rosen, K. Iwarsson, S.O. Ögren, and E. Brodin Increased levels of substance-P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and subchronic treatment with serotonin uptake inhibitor Acta Physiol. Scand. 136 1989 613 614 (Pubitemid 19209914)
9. A.K. Cadogan, D.A. Kendall, and C.A. Marsden Serotonin 5-HT1A receptor activation increases cyclic AMP formation in the rat hippocampus in vivo J. Neurochem. 62 1994 1816 1821
10. E. Carboni, V.G. Barros, M. Ibba, A. Silvagni, C. Mura, and M.C. Antonelli Prenatal restraint stress: an in vivo microdialysis study on catecholamine release in the rat prefrontal cortex Neuroscience 168 2010 156 166
11. L. Cervo, C. Rossi, E. Tatarczynska, and R. Samanin Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test Psychopharmacology (Berl) 109 1992 369 372
12. L.C. Chiou, Y.Y. Liao, P.C. Fan, P.H. Kuo, C.H. Wang, C. Riemer, and E.P. Prinssen Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications Curr. Drug Targets 8 2007 117 135 (Pubitemid 46043903)
13. H. Cohen, Z. Kaplan, M.A. Matar, I. Buriakovsky, M. Bourin, and M. Kotler Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats Depress. Anxiety 20 2004 139 152 (Pubitemid 39587565)
14. M. Duzzioni, F.S. Duarte, L.R. Leme, E.C. Gavioli, and T.C. De Lima Anxiolytic-like effect of central administration of NOP receptor antagonist UFP-101 in rats submitted to the elevated T-maze Behav. Brain Res. 222 2011 206 211
15. K. Ebner, S.B. Sartori, and N. Singewald Tachykinin receptors as therapeutic targets in stress-related disorders Curr. Pharm. Des. 15 2009 1647 1674
16. K. Ebner, and N. Singewald Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release Naunyn Schmiedebergs Arch. Pharmacol. 376 2007 73 82
17. M. Egawa, B.G. Hoebel, and E.A. Stone Use of microdialysis to measure brain noradrenergic receptor function in vivo Brain Res. 458 1988 303 308
18. P.C. Emson Complementary distribution of dopamine, substance P, and acetylcholine in the rat prefrontal cortex and septum Adv. Biochem. Psychopharmacol. 19 1978 397 400
19. E. Engin, J. Stellbrink, D. Treit, and C.T. Dickson Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence Neuroscience 157 2008 666 676
20. E. Engin, and D. Treit Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors Psychopharmacology (Berl) 206 2009 281 289
21. D. Feifel, T.L. Reza, D.J. Wustrow, and M.D. Davis Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist J. Pharmacol. Exp. Ther. 288 1999 710 713 (Pubitemid 29119685)
22. F. Fernandez, M.A. Misilmeri, J.C. Felger, and D.P. Devine Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety Neuropsychopharmacology 29 2004 59 71 (Pubitemid 38068014)
23. J.M. Finlay, M.J. Zigmond, and E.D. Abercrombie Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam Neuroscience 64 1995 619 628
24. 3H]nociceptin binding sites in the rat brain Brain Res. 880 2000 11 16
25. J. Ge, S.K. Long, and I.C. Kilpatrick Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain Eur. J. Pharmacol. 345 1998 163 170 (Pubitemid 28212347)
26. O. Godukhin, Z.B. You, M. Herrera-Marschitz, M. Goiny, E. Pettersson, T. Hokfelt, and U. Ungerstedt Effect of local cholecystokinin-8 administration on extracellular levels of amino acids and glycolytic products monitored by in vivo microdialysis in the fronto-parietal cortex of the rat Neurosci. Lett. 194 1995 29 32
27. C. Goeldner, W. Spooren, J. Wichmann, and E.P. Prinssen Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair Psychopharmacology (Berl) 2012
28. S.N. Goyal, M.A. Upadhya, D.M. Kokare, S.M. Bhisikar, and N.K. Subhedar Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors Brain Res. 1266 2009 45 53
29. P.J. Gresch, A.F. Sved, M.J. Zigmond, and J.M. Finlay Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat J. Neurochem. 63 1994 575 583 (Pubitemid 24233691)
30. G. Griebel, J. Simiand, C. Serradeil-Le Gal, J. Wagnon, M. Pascal, B. Scatton, J.P. Maffrand, and P. Soubrie Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders Proc. Natl. Acad. Sci. USA 99 2002 6370 6375 (Pubitemid 34493318)
31. E. Gur, E. Berman, B. Lerer, and M.E. Newman In vivo cyclic AMP responses in rat brain are not modified by chronic electroconvulsive shock Eur. Neuropsychopharmacol. 7 1997 189 193 (Pubitemid 27284497)
32. J. Harro, R.-A. Kiivet, A. Lang, and E. Vasar Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics Behav. Brain. Res. 39 1990 63 71 (Pubitemid 20182172)
33. M. Heilig, B. Soderpalm, J.A. Engel, and E. Widerlov Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models Psychopharmacology (Berl) 98 1989 524 529 (Pubitemid 19193902)
34. T. Hökfelt, C. Broberger, Z.Q. Xu, V. Sergeyev, R. Ubink, and M. Diez Neuropeptides-an overview Neuropharmacology 39 2000 1337 1356
35. M.J. Iadarola, J.R. Naranjo, A.M. Duchemin, and T.T. Quach Expression of cholecystokinin and enkephalin mRNA in discrete brain regions Peptides 10 1989 687 692 (Pubitemid 19167417)
36. M. Katayama, Y. Matsuda, K. Shimokawa, S. Tanabe, S. Kaneko, I. Hara, and H. Sato Simultaneous determination of six adenyl purines in human plasma by high-performance liquid chromatography with fluorescence derivatization J. Chromatogr. B Biomed. Sci. Appl. 760 2001 159 163 (Pubitemid 32718581)
37. H. Kawahara, Y. Kawahara, and B.H. Westerink The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain Eur. J. Pharmacol. 387 2000 279 286 (Pubitemid 30067829)
38. J. Kehr, and T. Yoshitake Monitoring brain chemical signals by microdialysis C.A. Grimes, E.C. Dickey, M.V. Pishko, Encyclopedia of Sensors vol. 6 2006 American Scientific Publishers California, Valencia 287 312
39. J. Korf, P.H. Boer, and D. Fekkes CYCLIC AMP/*SECRETl cyclic AMP into push-pull perfusates in freely moving rats Brain Res. 113 1976 551 561
40. S. Lazareno, D.B. Marriott, and S.R. Nahorski Differential effects of selective and non-selective neuroleptics on intracellular and extracellular cyclic AMP accumulation in rat striatal slices Brain Res. 361 1985 91 98 (Pubitemid 16185389)
41. Z. Li, M. Boules, K. Williams, J. Peris, and E. Richelson The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex Brain Res. 1311 2010 28 36
42. P.H. Luppi, G. Aston-Jones, H. Akaoka, G. Chouvet, and M. Jouvet Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin Neuroscience 65 1995 119 160
43. H. Maeno, H. Kiyama, and M. Tohyama Distribution of the substance P receptor (NK-1 receptor) in the central nervous system Brain Res. Mol. Brain Res. 18 1993 43 58
44. P.D. Marley, J.F. Rehfeld, and P.C. Emson Distribution and chromatographic characterisation of gastrin and cholecystokinin in the rat central nervous system J. Neurochem. 42 1984 1523 1535 (Pubitemid 14085635)
45. M. Marti, S. Stocchi, F. Paganini, F. Mela, C. De Risi, G. Calo, R. Guerrini, T.A. Barnes, D.G. Lambert, L. Beani, C. Bianchi, and M. Morari Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex Br. J. Pharmacol. 138 2003 91 98 (Pubitemid 36194207)
46. P. McGonigle Peptide therapeutics for CNS indications Biochem. Pharmacol. 83 2012 559 566
47. L.P. Montezinho, M.M. Castro, C.B. Duarte, S. Penschuck, C.F. Geraldes, and A. Mork The interaction between dopamine D2-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents J. Neurochem. 96 2006 1336 1348
48. L.P. Montezinho, A. Mork, C.B. Duarte, S. Penschuck, C.F. Geraldes, and M.M. Castro Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors Bipolar Disord. 9 2007 290 297 (Pubitemid 46552878)
49. D.A. Morilak, G. Barrera, D.J. Echevarria, A.S. Garcia, A. Hernandez, S. Ma, and C.O. Petre Role of brain norepinephrine in the behavioral response to stress Prog. Neuropsychopharmacol. Biol. Psychiatry 29 2005 1214 1224 (Pubitemid 41674636)
50. D.A. Morilak, M. Cecchi, and H. Khoshbouei Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress Life Sci. 73 2003 715 726 (Pubitemid 36703266)
51. A. Mork Actions of lithium on the cyclic AMP signalling system in various regions of the brain-possible relations to its psychotropic actions. A study on the adenylate cyclase in rat cerebral cortex, corpus striatum and hippocampus Pharmacol. Toxicol. 73 Suppl. 3 1993 1 47
52. A. Mork, and A. Geisler Effects of chronic lithium treatment on agonist-enhanced extracellular concentrations of cyclic AMP in the dorsal hippocampus of freely moving rats J. Neurochem. 65 1995 134 139
53. H. Nakane, N. Shimizu, and T. Hori Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis Am. J. Physiol. 267 1994 R1559 1566
54. Y. Nakaya, T. Kaneko, R. Shigemoto, S. Nakanishi, and N. Mizuno Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat J. Comp. Neurol. 347 1994 249 274 (Pubitemid 24273427)
55. C.B. Nemeroff Neurotensin: perchance an endogenous neuroleptic? Biol. Psychiatry 15 1980 283 302 (Pubitemid 10130688)
56. S.O. Ögren, E. Kuteeva, E. Elvander-Tottie, and T. Hökfelt Neuropeptides in learning and memory processes with focus on galanin Eur. J. Pharmacol. 626 2010 9 17
57. S.O. Ögren, E. Kuteeva, T. Hökfelt, and J. Kehr Galanin receptor antagonists: a potential novel pharmacological treatment for mood disorders CNS Drugs 20 2006 633 654 (Pubitemid 44141491)
58. S.O. Ögren, H. Razani, E. Elvander-Tottie, and J. Kehr The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders Physiol. Behav. 92 2007 172 179 (Pubitemid 47374240)
59. H. Okawa, M. Kudo, T. Kudo, R. Guerrini, D.G. Lambert, T. Kushikata, H. Yoshida, and A. Matsuki Effects of nociceptinNH2 and [Nphe1]nociceptin(1 ± 13)NH2 on rat brain noradrenaline release in vivo and in vitro Neuroscience Lett. 303 2001 173 176 (Pubitemid 32373283)
60. D.H. Overstreet, V.M. Naimoli, and G. Griebel Saredutant, an NK2 receptor antagonist, has both antidepressant-like effects and synergizes with desipramine in an animal model of depression Pharmacol. Biochem. Behav. 96 2010 206 210
61. E. Pallis, A. Vasilaki, D. Fehlmann, A. Kastellakis, D. Hoyer, C. Spyraki, and K. Thermos Antidepressants influence somatostatin levels and receptor pharmacology in brain Neuropsychopharmacology 34 2009 952 963
62. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1997 Academic Press California, San Diego
63. D. Quarta, C.P. Leslie, R. Carletti, E. Valerio, and L. Caberlotto Central administration of NPY or an NPY-Y5 selective agonist increase in vivo extracellular monoamine levels in mesocorticolimbic projecting areas Neuropharmacology 60 2011 328 335
64. A. Ramos-Salazar, and A.D. Baines Fluorometric determination of adenine nucleotides and adenosine by ion-paired, reverse-phase, high-performance liquid chromatography Anal. Biochem. 145 1985 9 13 (Pubitemid 15143075)
65. E. Ratti, K. Bellew, P. Bettica, H. Bryson, S. Zamuner, G. Archer, L. Squassante, A. Bye, D. Trist, K.R. Krishnan, and S. Fernandes Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorder J. Clin. Psychopharmacol. 31 2011 727 733
66. J.P. Redrobe, Y. Dumont, A. Fournier, and R. Quirion The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test Neuropsychopharmacology 26 2002 615 624 (Pubitemid 34260980)
67. G. Renoldi, and R.W. Invernizzi Blockade of tachykinin NK1 receptors attenuates stress-induced rise of extracellular noradrenaline and dopamine in the rat and gerbil medial prefrontal cortex J. Neurosci. Res. 84 2006 961 968 (Pubitemid 44521040)
68. M. Saffroy, Y. Torrens, J. Glowinski, and J.C. Beaujouan Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites Neuroscience 116 2003 761 773 (Pubitemid 36160572)
69. E.P. Schoener, P.J. Hager, B.T. Felt, and D.R. Schneider Cyclic nucleotides in the rat neostriatum: push-pull perfusion studies Brain Res. 179 1979 111 119 (Pubitemid 10160511)
70. J.A. Secrist 3rd, and N.J. Leonard Synthetic spectroscopic models related to coenzymes and base pairs. An "abbreviated" nicotinamide adenine dinucleotide J. Am. Chem. Soc. 94 1972 1702 1706
71. L.A. Selbie, and S.J. Hill G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways Trends Pharmacol. Sci. 19 1998 87 93 (Pubitemid 28197809)
72. C. Serradeil-Le Gal, J. Wagnon, J. Simiand, G. Griebel, C. Lacour, G. Guillon, C. Barberis, G. Brossard, P. Soubrie, D. Nisato, M. Pascal, R. Pruss, B. Scatton, J.P. Maffrand, and G. Le Fur Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl) -2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N, N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist J. Pharmacol. Exp. Ther. 300 2002 1122 1130 (Pubitemid 34165020)
73. P.D. Shilling, and D. Feifel The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle Pharmacol. Biochem. Behav. 90 2008 748 752
74. J.R. Shoblock The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity CNS Drug Rev. 13 2007 107 136 (Pubitemid 46697844)
75. R.A. Siegel, E.M. Düker, E. Fuchs, U. Pahnke, and W. Wuttke Responsiveness of mesolimbic, mesocortical, septal and hippocampal cholecystokinin and substance-P neuronal systems to stress, in the male rat Neurochem. Int. 6 1984 783 789 (Pubitemid 15182555)
76. E.A. Stone, and S.M. John In vivo measurement of extracellular cyclic AMP in the brain: use in studies of beta-adrenoceptor function in nonanesthetized rats J. Neurochem. 55 1990 1942 1949 (Pubitemid 120021824)
77. E.A. Stone, and S.M. John Further evidence for a glial localization of rat cortical beta-adrenoceptors: studies of in vivo cyclic AMP responses to catecholamines Brain Res. 549 1991 78 82
78. E.A. Stone, and S.M. John Stress-induced increase of extracellular levels of cyclic AMP in rat cortex Brain Res. 597 1992 144 147
79. J.C. Stoof, and J.W. Kebabian Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum Nature 294 1981 366 368 (Pubitemid 12202858)
80. C.J. Swanson, K.W. Perry, and D.D. Schoepp The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex J. Neurochem. 88 2004 194 202 (Pubitemid 38030222)
81. G.R. Uhl Distribution of neurotensin and its receptor in the central nervous system Ann. NY Acad. Sci. 400 1982 132 149 (Pubitemid 13138570)
82. F. Vallebuona, and M. Raiteri Monitoring of cyclic GMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity Neuroscience 57 1993 577 585 (Pubitemid 23350548)
83. E. Vasar, E. Peuranen, J. Harro, A. Lang, L. Oreland, and P.T. Männistö Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein Naunyn Schmiedebergs Arch. Pharmacol. 348 1993 96 101 (Pubitemid 23205645)
84. S. Wang, T. Hashemi, S. Fried, A.L. Clemmons, and B.E. Hawes Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes Biochemistry 37 1998 6711 6717 (Pubitemid 28228104)